Tokyo, July 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058497) titled 'A crossover open-label study comparing the gut environment improving effects of two strains of Bifidobacterium' on July 17.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Dose comparison
Primary Sponsor:
Institute - NISSIN YORK CO., LTD.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to exploratory evaluate the effects on the intestinal environment of taking a bifidobacteria-containing supplement (dead bac...